Patients’ #1 Digital Companions – On Time and On Budget
Get ahead with our expert guides to launching a successful digital companion for your patient programs.
"Must-Have" Budget Guides for Digital Decision-Makers
Build vs Buy Myths
Secrets to a Successful Launch
This free launch toolkit has the must-have answers and best practices for all eight stages of a launch.
New Data: Digital Numbers Are In
Value the Impact of Digital
How execs identify overall economic impact of digital solutions for improved adherence, persistence and more.
Pro Tips: Craft an Effective RFP
7 Questions to Ask Digital Vendors
Use these tips and criteria for your RFP questions and know what answers to demand from qualified partners.
Pharma's Latest Successes
Patient Support, Reimagined
Watch how digital accelerates patient support solutions while lessening the burden on care support teams.
Build Vs. Buy Myths
Here's everything pharma execs need to know about the eight stages of launching a digital companion.
Patient Engagement, Personalized
Take three minutes to see how digital solutions allow pharma to deliver personalized ‘white-glove’ patient journeys at scale.
Pro Tips: Craft an Effective RFP
Use these tips and criteria for your RFP questions and know what answers to demand from qualified partners.
The Digital Numbers Are In
Pharma execs now know the economic impact of digital solutions for improved adherence, persistence and more.
Patient Support, Reimagined
What Pharma is finding when implementing technology into existing model of support (video, 3 minutes).
How digital technology centralizes elements of patient support portfolio-wide without sacrificing brand identity.
Digital Drug Companion
Medication Engagement Platform
Patients receive complete treatment management through a combination of advanced technology and expert knowledge. Connect patients with an innovative digital platform that drives medication engagement, integrates human support and delivers a holistic care experience.
Download Medisafe:
Latest From Medisafe
Transforming Breast Cancer Care: Proven Adherence Gains for Pharma Execs
Summary Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250 breast cancer–related deaths projected in the United States in 2025 (American Cancer Society, 2025). Despite advances in targeted oral therapies for extended adjuvant treatment, real‐world studies find that up to 50% of patients discontinue or skip doses, undermining efficacy (Mayo Clinic, 2024). Pharmaceutical stakeholders…